Literature DB >> 2547411

The effect of indomethacin and enalapril on the cutaneous response to bradykinin.

L G McAlpine1, N C Thomson.   

Abstract

The angiotensin converting enzyme inhibitors potentiate the wheal response to intradermal bradykinin. Both converting enzyme inhibitors and bradykinin stimulate prostaglandin synthesis and prostaglandins enhance the cutaneous response to bradykinin. We examined the possibility that the increased wheal response to intradermal bradykinin in the presence of enalapril was due to the effect of prostaglandins. Indomethacin did not inhibit the potentiation by enalapril of the wheal response to bradykinin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547411      PMCID: PMC1379817          DOI: 10.1111/j.1365-2125.1989.tb03452.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Prostaglandin biosynthesis by rabbit renomedullary interstitial cells in tissue culture. Stimulation by angiotensin II, bradykinin, and arginine vasopressin.

Authors:  R M Zusman; H R Keiser
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

2.  Bradykinin induced wheal and flare is not mediated by histamine release or cyclooxygenase products.

Authors:  D C Crossman; R W Fuller
Journal:  Br J Clin Pharmacol       Date:  1988-07       Impact factor: 4.335

3.  Time-dependent inhibition of platelet cyclooxygenase by indomethacin is slowly reversible.

Authors:  R W Walenga; S F Wall; B N Setty; M J Stuart
Journal:  Prostaglandins       Date:  1986-04

4.  A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin.

Authors:  H Y Yang; E G Erdös; Y Levin
Journal:  Biochim Biophys Acta       Date:  1970-08-21

5.  Evidence in man of synergistic interaction between putative mediators of acute inflammation and asthma.

Authors:  G S Basran; J Morley; W Paul; M Turner-Warwick
Journal:  Lancet       Date:  1982-04-24       Impact factor: 79.321

6.  Effect of enalapril on the skin response to bradykinin in man.

Authors:  R W Fuller; J B Warren; M McCusker; C T Dollery
Journal:  Br J Clin Pharmacol       Date:  1987-01       Impact factor: 4.335

7.  Renin- and non-renin-mediated antihypertensive actions of converting enzyme inhibitors.

Authors:  R M Zusman
Journal:  Kidney Int       Date:  1984-06       Impact factor: 10.612

8.  Aspirin causes short-lived inhibition of bradykinin-stimulated prostacyclin production in man.

Authors:  D J Heavey; S E Barrow; N E Hickling; J M Ritter
Journal:  Nature       Date:  1985 Nov 14-20       Impact factor: 49.962

9.  Bradykinin-induced bronchoconstriction in humans. Mode of action.

Authors:  R W Fuller; C M Dixon; F M Cuss; P J Barnes
Journal:  Am Rev Respir Dis       Date:  1987-01

10.  Arachidonic acid-induced platelet aggregation and prostanoid formation in whole blood in relation to plasma concentration of indomethacin.

Authors:  E Vinge
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

View more
  4 in total

1.  The effect of sulindac on dermal responses to bradykinin in normal subjects given an angiotensin converting enzyme inhibitor.

Authors:  R E Ferner; F Kamali; M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1990-03       Impact factor: 4.335

2.  Effect of enalapril on allergen-induced cutaneous hypersensitivity reaction.

Authors:  J R Snyman; D K Sommers
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

3.  Cutaneous blood flow changes and weal induced by intradermal bradykinin following pretreatment with indomethacin and captopril.

Authors:  T C Wa; E D Cooke; P Turner
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 4.  Enalapril. A reappraisal of its pharmacology and therapeutic use in hypertension.

Authors:  P A Todd; K L Goa
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.